CODX vs VTRS · rev $3.9M vs rev $14.74B
Co-Diagnostics, Inc. Common Stock (CODX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
CODX currently screens at market cap $31.4M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the CODX and VTRS stock pages for the full models.
Not investment advice.